approval · primary record
INFLIXIMAB-ABDA
FDA · BLA · 2025-10-28
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-28 |
| Brand | RENFLEXIS |
| Sponsor | SAMSUNG BIOEPIS CO LTD |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:28.037Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INFLIXIMAB-ABDA:2025-10-28
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.